Phibro Animal Health Corporation (PAHC) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.045x

Based on the latest financial reports, Phibro Animal Health Corporation (PAHC) has a cash flow conversion efficiency ratio of 0.045x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($16.21 Million) by net assets ($361.83 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Phibro Animal Health Corporation defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Phibro Animal Health Corporation - Cash Flow Conversion Efficiency Trend (2000–2025)

This chart illustrates how Phibro Animal Health Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Phibro Animal Health Corporation Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Phibro Animal Health Corporation ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
YALLA GROUP SP.ADS/1 CL.A
F:80Q
N/A
ESGL Holdings Limited
NASDAQ:OIO
-0.041x
GeoPark Ltd
NYSE:GPRK
0.095x
Safe Bulkers Inc
NYSE:SB
0.040x
DAKOTA GOLD CORP. DL-001
F:RR6
-0.063x
2G Energy AG
XETRA:2GB
-0.175x
Inti Bangun Sejahtera Tbk
JK:IBST
0.171x
Anel Elektrik Proje Taahhut ve Ticaret AS
IS:ANELE
-0.029x

Annual Cash Flow Conversion Efficiency for Phibro Animal Health Corporation (2000–2025)

The table below shows the annual cash flow conversion efficiency of Phibro Animal Health Corporation from 2000 to 2025. For the full company profile with market capitalisation and key ratios, see Phibro Animal Health Corporation market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 $285.68 Million $80.12 Million 0.280x -17.83%
2024-06-30 $256.64 Million $87.59 Million 0.341x +624.44%
2023-06-30 $282.51 Million $13.31 Million 0.047x -60.93%
2022-06-30 $262.44 Million $31.65 Million 0.121x -40.45%
2021-06-30 $238.53 Million $48.31 Million 0.203x -35.78%
2020-06-30 $188.20 Million $59.35 Million 0.315x +44.41%
2019-06-30 $216.01 Million $47.17 Million 0.218x -42.31%
2018-06-30 $184.95 Million $70.01 Million 0.379x -41.85%
2017-06-30 $151.16 Million $98.40 Million 0.651x +58.26%
2016-06-30 $90.48 Million $37.22 Million 0.411x -82.26%
2015-06-30 $29.63 Million $68.70 Million 2.319x +5033.82%
2014-06-30 $15.15 Million $-712.00K -0.047x -680.74%
2013-06-30 $-68.94 Million $415.00K -0.006x +98.34%
2012-06-30 $-88.23 Million $31.99 Million -0.363x +51.24%
2009-06-30 $-53.88 Million $40.06 Million -0.744x -1483.27%
2007-06-30 $-88.00 Million $-4.73 Million 0.054x +655.42%
2006-06-30 $-83.70 Million $810.00K -0.010x -107.05%
2005-06-30 $-44.90 Million $-6.16 Million 0.137x +406.05%
2004-06-30 $-63.80 Million $2.86 Million -0.045x +89.06%
2003-06-30 $-84.60 Million $34.66 Million -0.410x -627.86%
2002-06-30 $-61.20 Million $-4.75 Million 0.078x -97.99%
2001-06-30 $3.40 Million $13.14 Million 3.865x +1648.81%
2000-06-30 $31.70 Million $-7.91 Million -0.250x --

About Phibro Animal Health Corporation

NASDAQ:PAHC USA Drug Manufacturers - Specialty & Generic
Market Cap
$671.46 Million
Market Cap Rank
#10981 Global
#2801 in USA
Share Price
$31.87
Change (1 day)
-1.27%
52-Week Range
$23.88 - $59.58
All Time High
$59.58
About

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including po… Read more